2Thomsen H S.Guidelines for contrast media from the European Society of Urogenital Radiology[J].Am J Roentgenol,2003,181(5):1463-1471. 被引量:1
3McCullough P A.Contrast-induced acute kidney injury[J].J Am Coll Cardiol,2008.51(15):1419-1428. 被引量:1
4Waikar S S,Bonventre J V.Creatinine kinetics and the definition of acute kindey injury[J].J Am Soc Nephrol,2009,20(3):672-679. 被引量:1
5Solomon R J,Mehran R,Natarajan M K,et al.Contrast-induced nephropathy and long-term adverse events:cause and effect[J]?Clin J Am Soc Nephrol,2009,4(7):1162-1169. 被引量:1
6Subramanian S,Tumlin J,Bapat B,et al.Economic burden of contrast induced nephropathy:implications for prevention strategies[J].Med Econ,2007,10(2):119-134. 被引量:1
7Mehran R,Aymong E D,Nikolsky E,et al.A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention[J].J Am Coll Cardiol,2004,44(7):1393-1399. 被引量:1
8Vercellino M,Bezante G P,Balbi M.Contrast medium induced nephropathy:new insights into prevention and risk management[J].Cardiovasc Hematol Agents Med Chem,2009,7(2):166-180. 被引量:1
9Laskey W K,Jenkins C,Selzer F,et al.Volume-to-creatinine clearance ratio:a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention[J].J Am Coll Cardiol,2007,50(7):584-590. 被引量:1
10Giancarlo M,Emilio A,Jeness C.Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality[J].Ann Inter Med,2009,150(3):170-177. 被引量:1